1. Home
  2. CDZI vs CLLS Comparison

CDZI vs CLLS Comparison

Compare CDZI & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CADIZ Inc.

CDZI

CADIZ Inc.

N/A

Current Price

$5.28

Market Cap

443.8M

Sector

Utilities

ML Signal

N/A

Logo Cellectis S.A.

CLLS

Cellectis S.A.

N/A

Current Price

$3.88

Market Cap

374.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CDZI
CLLS
Founded
1983
1999
Country
United States
France
Employees
25
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
443.8M
374.2M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
CDZI
CLLS
Price
$5.28
$3.88
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
619.1K
30.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$64.02
$40.37
Revenue Next Year
$28.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.13
$1.10
52 Week High
$6.96
$5.48

Technical Indicators

Market Signals
Indicator
CDZI
CLLS
Relative Strength Index (RSI) 47.48 51.03
Support Level $5.21 $3.41
Resistance Level $5.99 $4.46
Average True Range (ATR) 0.24 0.16
MACD 0.03 -0.00
Stochastic Oscillator 24.54 48.70

Price Performance

Historical Comparison
CDZI
CLLS

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: